Previous studieshave indicated that low serum albumin concentration is associated with anincreased risk of adverse cardiovascular events in CAD patients [17, 18].Fibrinogen-to-albumin ratio (FAR) is an innovative inflammatory biomarker thatcombines the above two indicators and has been widely used to predict adverseprognosis among patients with various cancers [19, 20]. Here, ALB is linked to cancer.